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Introduction
Antibiotics have been the cornerstone of modern medicine saving lives by virtue of being able to cure infectious diseases and to prevent infections in those that are immune compromised. [1] [2] [3] [4] Their intense use has led to a surging increase in the incidence of antibiotic-resistant bacteria resulting in a desperate need for antibiotics with new mechanisms of action. A strategy for overcoming bacterial resistance is to identify compounds that can circumvent the drug-resistant phenotype, enhancing or restoring the activity of antibiotics that are currently ineffective. [1] [2] [3] Polyamine-containing derivatives have been previously reported to enhance the activity of antibiotics, with simple unsubstituted polyamines, such as spermine and spermidine, having been found to act synergistically with a range of antibiotics to enhance the kill of a number of different Gram-positive and Gram-negative bacteria, but at an extraordinarily high dose of 1 mM. 5, 6 A recent study on polyamine-containing natural products identified squalamine (1) and ianthelliformisamine C (2) ( Fig. 1) , as being intrinsically antimicrobial and also being able to enhance the activity of antibiotics. [7] [8] [9] Ianthelliformisamine C (2) was shown to exhibit antimicrobial activity against Staphylococcus aureus and Klebsiella pneumoniae (MIC 12.5 and 12.5 µM, respectively) and to enhance the activity of doxycycline against both microbes (MIC 12.5 and 12.5, respectively) as well as Pseudomonas aeruginosa (MIC 3.12 µM). Mechanism of action studies suggest squalamine (1) functions by disruption of the outer-membrane of Gram-negative bacteria while ianthelliformisamine C (2) , in contrast, inhibits efflux pumps. 7, 10 Being suitably intrigued by these findings and given our ongoing interest in biologically active polyamine derivatives, [11] [12] [13] [14] we screened an in-house library of polyamine alkaloids related to the natural product ianthelliformisamine C (2)) for antimicrobial and antifungal properties and for the ability to restore the antibiotic activity of doxycycline towards P. aeruginosa. Herein we present this preliminary data, a structure-activity relationship study that explores the influence of the polyamine core on observed intrinsic antimicrobial properties and the ability to potentiate the action of doxycycline, and mechanism of action studies that evaluated compound influence on membrane permeability and polarization.
Results and Discussion
Our screening identified two 6-bromoindolglyoxylamide compounds, spermine 3 13 and spermidine 4 13 (Fig. 1 ) that exhibited good antimicrobial activity against two Gram-positive strains bacteria Staphylococcus intermedius (MIC 3.125 and 3.125 µM, respectively) and S. aureus (MIC 6.25 and 3.125 µM, respectively) and moderate to strong antifungal activity towards Candida albicans (MIC 17.2 µM for 3) and Cryptococcus neoformans (MIC 1.1 and 50 M, respectively) ( Table 1 ). These two hits were then evaluated for the ability to enhance the antibiotic activity of doxycycline towards Pseudomonas aeruginosa ATCC 27853. While doxycycline alone is ineffectual against this bacterial strain (MIC 64 g/mL), a combination of doxycycline at 2 g/mL with 3 at 6.25 µM was able to restore the action of the antibiotic (Table 2) . Somewhat surprisingly, the closely related spermidine hit compound 4 was found to be completely ineffective at restoring the action of doxycycline. In an effort to further expand on these initial findings, we prepared a series of analogues 7-15 ( Fig. 2 ) that explored the influence of the polyamine core on the observed biological activities. 
Chemistry
Synthesis of the target 6-bromoindolglyoxylamide derivatives 5, 6, 8 and 9 (Fig. 2 ) was achieved by a two-step sequence starting with reaction of 2-(6-bromo-1H-indol-3-yl)-2-oxoacetyl chloride (16) 15 with di-tert-butyl hexane-1,6-diylbis((3-aminopropyl)carbamate), 14 di-tert-butyl heptane-1,7-diylbis((3aminopropyl)carbamate), 14 di-tert-butyl decane-1,10-diylbis((3-aminopropyl)carbamate) 14 or di-tert-butyl dodecane-1,12-diylbis((3-aminopropyl)carbamate) 14 to afford a series of Boc protected intermediates (Scheme 1). These crude reaction intermediates were then directly subjected to Boc group deprotection, with TFA in CH 2 Cl 2 , to give tetraamine diamides 5, 6, 8 and 9 as their corresponding di-TFA salts (Scheme 1). The synthesis of 7 has been reported previously. 13 Reagents and conditions: a) Boc-protected polyamine (0.5 eq.), DIPEA (3 eq.), DMF, r. 
Scheme 2
General method for the preparation of analogues 10-15.
Reagents and conditions: a) RNH 2 (1 eq.), PyBOP (1 eq.), Et 3 N (6 eq.), DMF, r.t., 24 h, 20-82%.
Results and Discussion
The library of analogues were evaluated for activity against a variety of Gram-negative (Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii) and Gram-positive bacteria (Staphylococcus aureus and Staphylococcus intermedius) as well as two yeast strains (Candida albicans and Cryptococcus neoformans) ( Table 1) . As a general trend, those analogues with a polyamine core (3, 4, 5-9)
exhibited more pronounced activity than the non-polyamine (13) or shorter chained (10, 11, 12, 14, 15) derivatives. Within the polyamine examples, the presence of only one mid-chain nitrogen (4) reduced potency towards yeast, while the length of the polyamine mid-section gave maximal potency at PA3-10-3, with 8
exhibiting relatively broad-spectrum activity. We next evaluated the library of compounds for the ability to enhance the activity of doxycycline towards P.
aeruginosa ( Table 2 ). In the presence of doxycycline (2 g/mL), polyamines 5 and 8 were found to have strong enhancing effects (6.52 M and 6.16 M, respectively), with 6 and 7 being slightly less efficient. The absence of potentiating activity for not only non-polyamine analogues 10-15 but also polyamine analogue 9 and spermidine 4 implies narrow structural specificity for the observed activity. Table 4 ). The other compounds in the library were only weakly cytotoxic. Human red blood cell haemolytic activity was observed for three (5, 8, 9) of the seven polyamines, with 3, 4, 6, 7 having HC 10 values typically greater than 32 M. Lipophilic polyamines are noted for their abilities to increase the permeability of bacterial outer membranes, with examples including squalamine, 10 ianthelliformisamine derivatives, 7 claramine, 16 and naphthylacetylspermine. 17 An increase in membrane permeability is linked to bacterial cell death (antimicrobial activity) and also with the ability to enhance the action of hydrophobic antibiotics. 17 The effect of 3 on bacterial membrane integrity of Gram-negative (Pseudomonas aeruginosa PAO1) and Grampositive (Staphylococcus aureus) bacteria was assessed by measuring intracellular ATP release using a bioluminescence method. Brief (1 min) exposure of cells to 3 led to dose-dependent increases in extracellular ATP. In the case of P. aeruginosa (Fig. 3 ), rapid ATP leakage was detected with a higher response than that observed for the positive control, surfactant cetyltrimethylammonium bromide (CTAB), while the polyamine negative control, spermine, showed no such effect. Experiments using 3 (at ~10 µg/mL) and an increased concentration of CTAB (1%) revealed that 10% of the intracellular ATP was released after only a few seconds of contact (data not shown) suggesting a rapid disruption of the membrane barrier of the Gram-negative bacterium. Similar studies were conducted against the Gram-positive S. aureus strain where bromide 3 also caused rapid ATP leakage in a dose dependent manner ( Fig. 4 ) albeit at a lower rate than the positive control, CTAB.
Between them, the ATP leakage assays established that 3 can disrupt the integrity of bacterial membranes. The noted ability of 3 to enhance the antibiotic action of doxycycline towards a range of Gram negative bacteria (Table 3 ) may arise from the polyamines ability to inhibit drug efflux systems. In particular, efflux pumps are often associated with the inherent resistance of P. aeruginosa. 18, 19 In order to actively pump foreign molecules including antibiotics against their concentration gradient, an energy source such as a proton concentration gradient is required. Perturbation of the inner membrane through depolarisation causes loss of the proton concentration gradient resulting in the loss of the energy needed to efflux foreign compounds. 18, 19 To better understand whether 3 can act as a disruptor of the transmembrane potential, a real-time efflux assay was utilised. 20 This assay makes use of the membrane-potential-sensitive probe DiSC 3 (5) , which when preloaded into bacteria, concentrates in the inner membrane and quenches its own fluorescence. Upon membrane depolarisation, the dye is released and an increase in fluorescence (measured in relative fluorescence units) is observed. In a single-dose (10.4 M) 15 min incubation experiment, strong depolarization was observed against both P. aeruginosa PAO1 and S. aureus ATCC25923 with a particularly strong response from the Grampositive strain (Fig. 5 ). Negligible effect was observed for the negative control spermine. Closer examination of the membrane depolarization of S. aureus exhibited by 3 identified a dose-dependent response, with a rapid and strong in fluorescence (RFU), as also observed for the positive control, squalamine ( Fig. 6 ). Taken together these results suggest that the intrinsic antimicrobial activity of 3 may arise from rapid disruption of cell membrane integrity, resulting in the loss of cell wall rigidity, leading to cell death while the antibiotic potentiating ability may arise from indirect efflux pump inhibition via depolarisation of the membrane.
Conclusion
Our initial screening identified 6-bromoindolglyoxylamides 3 and 4 as modest to moderately active antimicrobial agents with 3 also exhibiting the ability to enhance the antibiotic action of doxycycline and erythromycin towards a number of the Gram-negative bacteria including Pseudomonas aeruginosa, Escherichia coli and Acinetobacter baumannii. Preliminary exploration of the findings identified that longer polyamine chain analogues could exhibit more pronounced antimicrobial properties, and this peaked with the polyamine PA3-8-3 core for antibacterial activity and for the PA3-10-3 core for antifungal properties. Analogues that lacked a polyamine core were essentially devoid of antimicrobial activity. Antibiotic potentiating activity required the presence of a polyamine scaffold, with 3, 5 and 8 being the most potent enhancers. Mechanism of action studies identified 3 as being able to disrupt the integrity of, and depolarize, bacterial membranes. The therapeutic potential of this class of compound is however limited by the observation of cytotoxicity, overcoming which is the focus of current studies.
Experimental

General remarks
Infrared spectra were recorded on a Perkin-Elmer spectrometer 100 Fourier Transform infrared spectrometer equipped with a universal ATR accessory. Mass spectra were acquired on a Bruker micrOTOF Q II 14 and di-tert-butyl dodecane-1,12-diylbis((3-aminopropyl)carbamate) 14 were synthesised by literature procedures.
Synthesis of compounds
General procedure for the preparation of compounds 5, 6, 8 and 9.
A two-step sequence was used for the preparation of these target compounds. In the first step, reaction of 2-(6bromo-1H-indol-3-yl)-2-oxoacetyl chloride 16 15 (2 eq.) and the appropriate Boc protected polyamine 14 (1 eq.) in DMF (1 mL) with DIPEA (6 eq.) were stirred for 48 h before solvent removal under reduced pressure. The crude reaction product was then subjected to Boc deprotection without any purification. A solution of crude tertbutyl-carboxylate derivative in CH 2 Cl 2 (2 mL) and TFA (0.2 mL) was stirred at room temperature under N 2 for 2 h followed by solvent removal under reduced pressure. The reaction product was purified using C 8 reversedphase column chromatography [0%-50% MeOH/H 2 O (0.05% TFA)] to afford derivatives 5, 6, 8 and 9 as their di-TFA salt. 2.1.1. N 1 ,N 6 -Bis(3-(2-(6-bromo-1H-indol-3-yl 017 g, 15%) . A sub-sample of this material (0.008 g, 0.008 mmol) was then deprotected by reaction with TFA (0.2 mL) in CH 2 Cl 2 (2 mL) to give a crude product that was purified by C 8 13 
5.
N 1 ,N 7 -Bis(3-(2-(6-bromo-1H-indol-3-yl)-2-oxoacetamido)propyl)heptane-1,7-diaminium 2,2,2trifluoroacetate (6)
Following the general procedure, to a solution of 2-(6-bromo-1H-indol-3-yl)-2-oxoacetyl chloride 15 2.1.3. N 1 ,N 10 -bis(3-(2-(6-bromo-1H-indol-3-yl)-2-oxoacetamido) propyl)decane-1,10-diaminium 2,2,2-
5.
trifluoroacetate (8)
Following the general procedure, to a solution of 2-(6-bromo-1H-indol-3-yl)-2-oxoacetyl chloride 15 (0.076 g, 0.27 mmol) in DMF (2 mL) was added DIPEA (0.14 mL, 0.80 mmol) and di-tert-butyl decane-1,10-diylbis((3aminopropyl)carbamate) 14 (0.063 g, 0.13 mmol). The reaction mixture was stirred at room temperature for 48 h under N 2 . The crude product was dissolved in CH 2 Cl 2 (20 mL), washed with brine (2 x 20 mL) and the solvent removed in vacuo to afford di-tert-butyl decane-1,10-diylbis((3-(2-(6-bromo-1H-indol-3-yl)-2oxoacetamido)propyl)carbamate) as a dark orange oil (0.42 g, 33%). A sub-sample of this material (0.014 g, 0.014 mmol) was then deprotected by reaction with TFA (0.2 mL) in CH 2 Cl 2 (2 mL) to give a crude product that was purified by C 8 13 
5.2.2
General procedure for the preparation of analogues 10-15.
To a stirred solution of 2-(6-bromo-1H-indol-3-yl)-oxoacetic acid (17) 11 (1 eq.) and diamine (1 eq.) in DMF (2 mL) was added PyBOP (1 eq.) and triethylamine (3 eq.). The reaction mixture was stirred for 24 h at room temperature under N 2 . To the crude reaction product was added CH 2 Cl 2 (30 mL) and the organic layer washed with aq. K 2 CO 3 (1%, 2 x 30 mL) followed by water (2 x 30 mL). The organic extract was concentrated under reduced pressure and subjected to purification (as described below) to afford the target compound.
2-(6-Bromo-1H-indol-3-yl)-N-(3-((2-(2-(6-bromo-1H-indol-3-yl)-2oxoacetamido)ethyl)amino)propyl)-2-oxoacetamide (10)
Following the general procedure, 17 11 N,N'-(Butane-1,4-diyl)bis(2-(6-bromo-1H-indol-3 
5.2.2.2.
-yl)-2-oxoacetamide) (11)
Following the general procedure, 17 11 (0.091 g, 0.340 mmol) was reacted with 1,4-diaminobutane (0.015 g, 0.170 mmol), PyBOP (0.177 g, 0.340 mmol) and triethylamine (0.142 mL, 1.02 mmol) in DMF for 24 h. The crude reaction product was concentrated under reduced pressure and washed with MeOH/water (4:1) to afford
Antibiotics
Doxycycline was purchased from TCI Europe and dissolved in water.
Antimicrobial evaluation
The susceptibility of bacterial strains to antibiotics and compounds was determined in microplates using the standard broth dilution method in accordance with the recommendations of the Comité de l'AntibioGramme de la Société Française de Microbiologie (CA-SFM). Briefly, the minimal inhibitory concentrations (MICs) were determined with an inoculum of 10 5 CFU in 200 µL of MH broth containing two-fold serial dilutions of each drug. The MIC was defined as the lowest concentration of drug that completely inhibited visible growth after incubation for 18 h at 37 °C. To determine all MICs, the measurements were independently repeated in triplicate.
Determination of the MICs of antibiotics in the presence of synergising compounds
Briefly, restoring enhancer concentrations were determined with an inoculum of 5 10 5 CFU in 200 µL of MH broth containing two-fold serial dilutions of each derivative in the presence of doxycycline at 2 µg/mL. The lowest concentration of the polyamine adjuvant that completely inhibited visible growth after incubation for 18 h at 37 °C was determined. These measurements were independently repeated in triplicate.
Measurement of ATP efflux
General procedure illustrated with CTAB (0.1%) CTAB solutions (0.1%) were prepared in doubly distilled water at different concentrations. A suspension of growing S. aureus (ATCC25923) or P. aeruginosa (PAO1) to be studied in MH broth was prepared and incubated at 37 °C. This suspension (90 µL) was added to 10 µL of CTAB solution and vortexed for 1 sec.
Luciferin-luciferase reagent (Yelen, France; 50 µL) was immediately added to the precedent mix and luminescent signal quantified with an Infinite M200 microplate reader (Tecan) for five secs. ATP concentration was quantified by internal sample addition. A similar procedure was used for negative control spermine (100 µg/mL) and for for test compound 3 (4 times the MIC).
Membrane depolarisation assays
Bacteria were grown in MH broth for 24 h at 37 °C and centrifuged at 10000 rpm at 20 °C. The supernatant was discarded and the bacteria were washed twice with buffered sucrose solution (250 mM) and magnesium sulfate solution (5 mM). The fluorescent dye 3,3′-diethylthiacarbocyanine iodide was added to a final concentration of 3 µM and allowed to penetrate into bacterial membranes during 1 h of incubation at 37 °C. Bacteria were then washed to remove the unbound dye before adding compound at different concentrations. Fluorescence measurements were performed using a Jobin Yvon Fluoromax 3 spectrofluorometer with slit widths of 5/5 nm.
The maximum RCF was considered to be that recorded with a pure solution of the fluorescent dye in buffer (3 µM).
